Jeffrey Chuang

Dr. Jeffrey Chuang

The Jackson Laboratory, Farmington, CT USA
+1

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2014 in Science
Verified
Journal Article
Closed access
PDF file
RIRyuta Ishimura
Ryuta Ishimura
GNGabor Nagy
Gabor Nagy
IDIvan Dotu
Ivan Dotu
HZHuihao Zhou
Huihao Zhou
XYXiang-Lei Yang
Xiang-Lei Yang
SASusan L. Ackerman
Susan L. Ackerman
Problems making proteins kills nerve cells: Neurodegeneration is associated with a variety of different diseases, but its cellular roots are often obscure. Ishimura et al. find that mutant mice whose brain cells start to die rapidly soon after birth have lost the function of two vital cellular components (see the Perspective by Darnell). The first is a protein that releases stalled ribosomes stuck on messenger RNA (mRNA); the second is a transfer RNA (tRNA), which reads the code for arginine in the mRNA. This tRNA is expressed predominantly in the central nervous system. The lack of the tRNA leads to increased ribosomal stalling at arginine codons, which, when left uncorrected, blocks protein synthesis and proves fatal. Science , this issue p. 455 ; see also p. 378

24 February 2022 in Nature Cancer
Verified
Journal Article
Open access
PDF file
KGKatrin P. Guillen
Katrin P. Guillen
MFMaihi Fujita
Maihi Fujita
ABAndrew J. Butterfield
Andrew J. Butterfield
SSSandra Daniela Scherer
Sandra Daniela Scherer
MBMatthew H. Bailey
Matthew H. Bailey
AWAlana L. Welm
Alana L. Welm
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures from tumors that represent the greatest unmet need: endocrine-resistant, treatment-refractory and metastatic breast cancers. We leverage matched PDXs and PDX-derived organoids (PDxO) for drug screening that is feasible and cost-effective with in vivo validation. Moreover, we demonstrate the feasibility of using these models for precision oncology in real time with clinical care in a case of triple-negative breast cancer (TNBC) with early metastatic recurrence. Our results uncovered a Food and Drug Administration (FDA)-approved drug with high efficacy against the models. Treatment with this therapy resulted in a complete response for the individual and a progression-free survival (PFS) period more than three times longer than their previous therapies. This work provides valuable methods and resources for functional precision medicine and drug development for human breast cancer.

27 June 2010 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
DCDong Cai
Dong Cai
LRLu Ren
Lu Ren
HZHuaizhou Zhao
Huaizhou Zhao
CXChenjia Xu
Chenjia Xu
LZLu Zhang
Lu Zhang
TCThomas C. Chiles
Thomas C. Chiles

14 December 2001 in Physical Review E
Verified
Journal Article
Closed access
PDF file
Jeffrey ChuangJeffrey Chuang
Jeffrey Chuang
YKYacov Kantor
Yacov Kantor
MKMehran Kardar
Mehran Kardar
We study the dynamics of the passage of a polymer through a membrane pore (translocation), focusing on the scaling properties with the number of monomers N. The natural coordinate for translocation is the number of monomers on one side of the hole at a given time. Commonly used models that assume Brownian dynamics for this variable predict a mean (unforced) passage time τ that scales as N2, even in the presence of an entropic barrier. In particular, however, the time it takes for a free polymer to diffuse a distance of the order of its radius by Rouse dynamics scales with an exponent larger than two, and this should provide a lower bound to the translocation time. To resolve this discrepancy, we perform numerical simulations with Rouse dynamics for both phantom (in space dimensions d=1 and 2), and self-avoiding (in d=2) chains. The results indicate that for large N, translocation times scale in the same manner as diffusion times, but with a larger prefactor that depends on the size of the hole. Such scaling implies anomalous dynamics for the translocation process. In particular, the fluctuations in the monomer number at the hole are predicted to be nondiffusive at short times, while the average pulling velocity of the polymer in the presence of a chemical-potential difference is predicted to depend on N.

1 December 2008 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
MKMichael A. Kiebish
Michael A. Kiebish
XHXianlin Han
Xianlin Han
HCHua Cheng
Hua Cheng
Jeffrey ChuangJeffrey Chuang
Jeffrey Chuang
TSThomas Seyfried
Thomas Seyfried
Michael A. Kiebish, Xianlin Han, Hua Cheng, Jeffrey H. Chuang, Thomas N. Seyfried

16 April 2016 in eLife
Verified
Journal Article
Open access
RIRyuta Ishimura
Ryuta Ishimura
GNGabor Nagy
Gabor Nagy
IDIvan Dotu
Ivan Dotu
Jeffrey ChuangJeffrey Chuang
Jeffrey Chuang
SASusan L Ackerman
Susan L Ackerman
Ribosome stalling during translation has recently been shown to cause neurodegeneration, yet the signaling pathways triggered by stalled elongation complexes are unknown. To investigate these pathways we analyzed the brain of C57BL/6J-Gtpbp2nmf205-/- mice in which neuronal elongation complexes are stalled at AGA codons due to deficiencies in a tRNAArgUCU tRNA and GTPBP2, a mammalian ribosome rescue factor. Increased levels of phosphorylation of eIF2α (Ser51) were detected prior to neurodegeneration in these mice and transcriptome analysis demonstrated activation of ATF4, a key transcription factor in the integrated stress response (ISR) pathway. Genetic experiments showed that this pathway was activated by the eIF2α kinase, GCN2, in an apparent deacylated tRNA-independent fashion. Further we found that the ISR attenuates neurodegeneration in C57BL/6J-Gtpbp2nmf205-/- mice, underscoring the importance of cellular and stress context on the outcome of activation of this pathway. These results demonstrate the critical interplay between translation elongation and initiation in regulating neuron survival during cellular stress.